Abstract
Mitochondrion, the energy generating organelle of the cell, is a subject of interest for selective targeting of therapeutic molecules, both Drugs and DNA, since it is found to be involved in numerous disorders like diabetes, neurodegenerative disease and cancer etc. Mitochondrial therapy can be made possible if the bioactive molecule is selectively delivered to the mitochondria of correct cell type, using cell specific ligands and mitochondriotropic molecules in designing of cell selective mitochondria specific carrier system. In this present review we will elaborate the role of mitochondria in human disease, cell specific ligands, mitochondriotropic molecules and their utilization in construction of such cell selective and mitochondria specific delivery systems that will make mitochondrial medicine practically possible.
Keywords: Mitochondria, mitochondriotropic, targeting, ligands, mitochondrial medicine
Current Drug Delivery
Title: Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Volume: 4 Issue: 3
Author(s): Rishi Paliwal, Shivani Rai, Bhuvaneshwar Vaidya, Sunil Mahor, Prem N. Gupta, Amit Rawat and S.P. Vyas
Affiliation:
Keywords: Mitochondria, mitochondriotropic, targeting, ligands, mitochondrial medicine
Abstract: Mitochondrion, the energy generating organelle of the cell, is a subject of interest for selective targeting of therapeutic molecules, both Drugs and DNA, since it is found to be involved in numerous disorders like diabetes, neurodegenerative disease and cancer etc. Mitochondrial therapy can be made possible if the bioactive molecule is selectively delivered to the mitochondria of correct cell type, using cell specific ligands and mitochondriotropic molecules in designing of cell selective mitochondria specific carrier system. In this present review we will elaborate the role of mitochondria in human disease, cell specific ligands, mitochondriotropic molecules and their utilization in construction of such cell selective and mitochondria specific delivery systems that will make mitochondrial medicine practically possible.
Export Options
About this article
Cite this article as:
Rishi Paliwal , Shivani Rai , Bhuvaneshwar Vaidya , Sunil Mahor , Prem N. Gupta , Amit Rawat and S.P. Vyas , Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine, Current Drug Delivery 2007; 4 (3) . https://dx.doi.org/10.2174/156720107781023910
DOI https://dx.doi.org/10.2174/156720107781023910 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MMP-9, a Potential Target for Cerebral Ischemic Treatment
Current Neuropharmacology Nanocapsulated Ascorbic Acid in Combating Cerebral Ischemia Reperfusion- Induced Oxidative Injury in Rat Brain
Current Alzheimer Research Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Transplantation Tolerance by Donor MHC Gene Transfer
Current Gene Therapy Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Innate Immune System in Inflammation and Cardiac Remodeling After Myocardial Infarction
Current Vascular Pharmacology The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies
Current Respiratory Medicine Reviews A Role for Endothelin-1 in Peripheral Vascular Disease
Current Vascular Pharmacology MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Inflammation & Allergy - Drug Targets (Discontinued) Effects of Kallistatin on Oxidative Stress and Inflammation on Renal Ischemia-Reperfusion Injury in Mice
Current Vascular Pharmacology Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design BK Channel Modulators: A Comprehensive Overview
Current Medicinal Chemistry Is the Multifunctional Na+/H+ Exchanger Isoform 1 a Potential Therapeutic Target in Cancer?
Current Medicinal Chemistry Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
Current Vascular Pharmacology Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Insulin Resistance and Postprandial Hyperglycemia the Bad Companions in Natural History of Diabetes: Effects on Health of Vascular Tree
Current Diabetes Reviews Sigma Receptor Activation Reduces Infarct Size at 24 Hours After Permanent Middle Cerebral Artery Occlusion in Rats
Current Neurovascular Research Progress in Drug Treatment of Cerebral Edema
Mini-Reviews in Medicinal Chemistry Adenosine and Adenosine Receptors: Their Contribution to Airway Inflammation and Therapeutic Potential in Asthma
Current Medicinal Chemistry Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets